Increase in E. active rosette forming lymphocytes in melanoma patients treated with BCG
- 31 May 1977
- journal article
- Published by Elsevier
- Vol. 13 (4-5) , 321-323
- https://doi.org/10.1016/0014-2964(77)90074-3
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Prognostic correlations in malignant melanomaPublished by Elsevier ,1975
- Thymus-derived lymphocytes in patients with solid malignanciesClinical Immunology and Immunopathology, 1975
- The immunologic and histopathologic changes of BCG-mediated tumor regression in patients with malignant melanomaCancer, 1975
- Tumor-Directed Immune Reactivity and Immunotherapy in Malignant Melanoma. Current Status1Published by S. Karger AG ,1973
- Immunologic Effects of BCG in Patients With Malignant Melanoma: Specific Evidence for Stimulation of the “Secondary” Immune ResponseJNCI Journal of the National Cancer Institute, 1973
- Thymus-Derived Rosette-Forming Cells in Various Human Disease States: Cancer, Lymphoma, Bacterial and Viral Infections, and Other DiseasesJournal of Clinical Investigation, 1973
- SURFACE MARKERS ON HUMAN T AND B LYMPHOCYTESThe Journal of Experimental Medicine, 1972